Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics

• Jamal Chauhan,

  Affiliations Department of Pharmaceutical Sciences, University of Maryland, School of Pharmacy, Baltimore, Maryland, United States of America, Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Steven Cardinale,

  Affiliation Microbiotix, Inc., One Innovation Drive, Worcester, Massachusetts, United States of America

  ⨯
• Lei Fang,

  Affiliations Department of Pharmaceutical Sciences, University of Maryland, School of Pharmacy, Baltimore, Maryland, United States of America, Computer-Aided Drug Design Center, University of Maryland, School of Pharmacy, Baltimore, Maryland, United States of America, Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Jing Huang,

  Affiliations Department of Pharmaceutical Sciences, University of Maryland, School of Pharmacy, Baltimore, Maryland, United States of America, Computer-Aided Drug Design Center, University of Maryland, School of Pharmacy, Baltimore, Maryland, United States of America

  ⨯
• Steven M. Kwasny,

  Affiliation Microbiotix, Inc., One Innovation Drive, Worcester, Massachusetts, United States of America

  ⨯
• M. Ross Pennington,

  Affiliation U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland, United States of America

  ⨯
• Kelly Basi,

  Affiliation U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland, United States of America

  ⨯
• Robert diTargiani,

  Affiliation U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland, United States of America

  ⨯
• Benedict R. Capacio,

  Affiliation U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland, United States of America

  ⨯
• Alexander D. MacKerell Jr,

  Affiliations Department of Pharmaceutical Sciences, University of Maryland, School of Pharmacy, Baltimore, Maryland, United States of America, Computer-Aided Drug Design Center, University of Maryland, School of Pharmacy, Baltimore, Maryland, United States of America

  ⨯
• Timothy J. Opperman,

  Affiliation Microbiotix, Inc., One Innovation Drive, Worcester, Massachusetts, United States of America

  ⨯
• Steven Fletcher,

  Affiliation Department of Pharmaceutical Sciences, University of Maryland, School of Pharmacy, Baltimore, Maryland, United States of America

  ⨯
• Erik P. H. de Leeuw

  * E-mail: edeleeuw@som.umaryland.edu

  Affiliation Institute of Human Virology & Department of Biochemistry and Molecular Biology of the University of Maryland Baltimore School of Medicine, Baltimore, Maryland, United States of America

  ⨯